Historical perspective of factor XI

Thrombosis Research

Volumn 115, Issue 6, 2005, Pages 441-450

  Fujikawa, Kazuo ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Factor XI; Hemophilia; Platelets Thrombin; Thromboplastin antecedent

Indexed keywords

BLOOD CLOTTING FACTOR 11; THROMBIN;

BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PURIFICATION; REVIEW; ULTRACENTRIFUGATION;

EID: 15744406020     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.10.013     Document Type: Review

References (84)

1. R.L. Rosenthal, O.H. Dreskin, and N. Rosenthal New hemophilia-like disease caused by deficiency of a third thromboplastin factor Proc. Soc. Exp. Biol. Med. 82 1953 171 174
2. P.M. Aggeler, S.G. White, M.B. Glendening, E.W. Page, T.B. Leake, and G. Bates Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia Proc. Soc. Exp. Biol. Med. 79 1952 692 694
3. O.D. Ratnoff, and J.E. Colopy A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma J. Clin. Invest. 34 1955 602 613
4. O.D. Ratnoff, and J. Rosenblum Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition Am. J. Med. 25 1958 160 168
5. O.D. Ratnoff, E.W. Davie, and D.L. Mallett Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent J. Clin. Invest. 40 1961 803 819
6. O.D. Ratnoff, and E.W. Davie The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI) Biochemistry 1 1962 677 685
7. H.S. Kingdon, E.W. Davie, and O.D. Ratnoff The reaction between activated plasma thromboplastin antecedent and diisopropylphosphorofluoridate Biochemistry 3 1964 166 173
8. S. Schiffman, and P. Lee Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factor XI and XII Br. J. Haematol. 27 1974 101 114
9. K.D. Wuepper Prekallikrein deficiency in man J. Exp. Med. 38 1973 1345 1355
10. H. Saito, O.D. Ratnoff, R. Waldmann, and J.P. Abraham Deficiency of hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reaction of clotting, fibrinolysis, generation of kinin, and the property of diluted plasma enhancing vascular permeability (PF/DIL) J. Clin. Invest. 55 1975 1082 1089
11. V.H. Donaldson, H.I. Glueck, M.A. Miller, H.Z. Movat, and F. Habal Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis J. Lab. Clin. Med. 87 1976 327 337
12. J.H. Griffin, and C.G. Cochrane Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor Proc. Natl. Acad. Sci. U. S. A. 73 1976 2554 2558
13. R.E. Thompson, R.J. Mandle, and A.P. Kaplan Association of factor XI and high molecular weight kininogen in human plasma J. Clin. Invest. 60 1977 1376 1380
14. V.H. Donaldson, J. Kleniewski, H. Saito, and J.K. Sayed Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma J. Clin. Invest. 60 1977 571 583
15. O.D. Ratnoff The biology and pathology of the initial stages of blood coagulation Prog. Hematol. 5 1966 204 205
16. H. Saito, O.D. Ratnoff, J.S. Marshall, and J. Pensky Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin J. Clin. Invest. 52 1973 850 861
17. G.J. Kociba, O.D. Ratnoff, W.F. Loeb, R.L. Wall, and L.E. Heider Bovine plasma thromboplastin antecedent (factor XI) deficiency J. Lab. Clin. Med. 74 1969 37 40
18. K. Koide, H. Kato, and E.W. Davie Isolation and characterization of bovine factor XI (plasma thromboplastin antecedent) Biochemistry 16 1977 2279 2286
19. T. Koide, M.A. Hermodoson, and E.W. Davie Active site of bovine factor XI (plasma thromboplastin antecedent) Nature 266 1977 729 730
20. K. Fujikawa, M.E. Legaz, H. Kato, and E.W. Davie The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent) Biochemistry 13 1974 4508 4516
21. K. Kurachi, and E.W. Davie Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor) Biochemistry 16 1977 5831 5839
22. J.F. Tait, and K. Fujikawa Primary structure requirements for the binding of human high molecular weight kininogen to prekallikrein and factor XI J. Biol. Chem. 263 1987 11651 11656
23. K. Fujikawa, D.W. Chung, L.E. Hendrickson, and E.W. Davie Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein Biochemistry 25 1986 2417 2424
24. B.A. McMullen, K. Fujikawa, and E.W. Davie Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains Biochemistry 30 1991 2056 2060
25. D.W. Chung, K. Fujikawa, B.A. McMullen, and E.W. Davie Human plasma prekallirein, a zymogen to a serine protease that contains four tandem repeats Biochemistry 25 1986 2410 2417
26. J.C. Meijers, E.R. Mulvihill, E. Davie, and D. Chung Apple four in human blood coagulation factor XI mediates dimer formation Biochemistry 31 1992 4680 4684
27. D. Gailani, D. Ho, M.F. Sun, Q. Cheng, and P.N. Walsh Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential Blood 97 2001 3117 3122
28. G.P. Tuszynski, S.J. Bevacqua, A.H. Schmaier, R.W. Colman, and P.N. Walsh Factor XI antigen and activity in human platelets Blood 59 1982 1148 1156
29. S. Schiffman, and C.H. Yeh Purification and characterization of platelet factor XI Thromb. Res. 60 1990 87 97
30. C.J. Hu, F.A. Baglia, D.C. Mills, B.A. Konkle, and P.N. Walsh Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression Blood 91 1998 3800 3807
31. T.C. Hsu, S.K. Shore, T. Seshsmma, O. Bagasra, and P.N. Walsh Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene J. Biol. Chem. 273 1998 13787 13793
32. D. Martincic, V. Kravtsov, and D. Gailani Factor XI messenger RNA in human platelets Blood 94 1999 3397 3404
33. D.S. Sinha, F. Seaman, A. Koshy, L.C. Knight, and P.N. Walsh Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI J. Clin. Invest. 73 1984 1550 1556
34. J.C. Greengard, M.J. Heeb, E. Ersdal, P.N. Walsh, and J. Griffin Binding of coagulation factor XI to washed human platelets Biochemistry 25 1986 3884 3890
35. F.A. Baglia, B.A. Jameson, and P.N. Walsh Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86 J. Biol. Chem. 265 1990 4149 4154
36. F.A. Baglia, B.A. Jameson, and P.N. Walsh Fine mapping of the high molecular weight kininogen binding site on blood coagulation factor XI through the use of rationally designed synthetic analogs J. Biol. Chem. 267 1992 4247 4252
37. F.S. Seaman, F.A. Baglia, J.A. Gurr, B.A. Jameson, and P.N. Walsh Binding of high-molecular-mass kininogen to the apple 1 domain of factor XI is mediated in part by Val64 and Ile77 Biochemistry 15 1994 715 721
38. F.A. Baglia, and P.N. Walsh A binding site for thrombin in the apple 1 domain of factor XI J. Biol. Chem. 271 1996 3652 3658
39. F.A. Baglia, K.O. Badellino, D.H. Ho, V.R. Dasari, and P.N. Walsh A binding site for the kringle II domain of prothrombin in the apple 1 domain of factor XI J. Biol. Chem. 275 2000 31954 31962
40. F.A. Baglia, B.A. Jameson, and P.N. Walsh Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa J. Biol. Chem. 266 1991 24190 24197
41. D.H. Ho, K. Badellino, F.A. Baglia, and P.N. Walsh A binding site for heparin in the apple 3 domain of factor XI J. Biol. Chem. 273 1998 16382 16390
42. F.A. Baglia, F.S. Seaman, and P.N. Walsh The apple 1 and apple 4 domains of factor XI act synergistically to promote the surface-mediated activation of factor XI by factor XIIa Blood 85 1995 2078 2083
43. D.H. Ho, F.A. Baglia, and P.N. Walsh Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain Biochemistry 39 2000 316 323
44. F.A. Baglia, B.A. Jameson, and P.N. Walsh Identification and characterization of a binding site for factor XIIa in the apple 4 domain of coagulation factor XI J. Biol. Chem. 268 1993 3838 3844
45. F.A. Baglia, B.A. Jameson, and P.N. Walsh Identification and characterization of a binding site for platelets in the apple 3 domain of coagulation factor XI J. Biol. Chem. 270 1995 6734 6740
46. M. Zhao, T. Abdel-Razek, M.F. Sun, and D. Gailani Characterization of a heparin binding site on the heavy chain of factor XI J. Biol. Chem. 273 1998 31153 31159
47. Y. Sun, and D. Gailani Identification of a factor IX binding site on the third apple domain of activated factor XI J. Biol. Chem. 271 1996 29023 29028
48. M.F. Sun, M. Zhao, and D. Gailani Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX J. Biol. Chem. 274 1999 36373 36378
49. T. Renne, D. Gailani, J.C. Meijers, and W. Muller-Esterl Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein J. Biol. Chem. 277 2002 4892 4899
50. A. Aktimur, M.A. Gabriel, D. Gailani, and J.R. Toomey The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa J. Biol. Chem. 278 2003 7981 7987
51. K. Naito, and K. Fujikawa Acivation of human blood coagulation factor XI independent of factor XII J. Biol. Chem. 266 1991 7353 7358
52. D. Gailani, and G.J. Broze Factor XI activation in a revised model of blood coagulation Science 253 1991 909 912
53. D. Gailani, and G.J. Broze Effects of glycosaminoglycans on factor XI activation by thrombin Blood Coagul. Fibrinolysis 4 1993 15 20
54. D. Gailani, and G.J. Broze Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation Blood 82 1993 813 819
55. G.J. Broze, T.J. Girard, and W.F. Novotny Regulation of coagulation by a multivalent Kunitz-type inhibitor Biochemistry 29 1990 7539 7546
56. P.A. von dem Borne, J.C. Meijers, and B.N. Bouma Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis Blood 86 1995 3035 3042
57. K.M. Cawthern, C. van't Veer, J.B. Lock, M.I. DiLorenzo, R.F. Branda, and K.G. Mann Blood coagulation in hemophilia A and hemophilia C Blood 91 1998 4581 4592
58. S. Butenas, C. van't Veer, and K.G. Mann Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases J. Biol. Chem. 272 1997 21527 21533
59. F.A. Baglia, and P.N. Walsh Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin Biochemistry 37 1998 2271 2281
60. J.A. Oliver, D.M. Monroe, H.R. Roberts, and M. Hoffman Thrombin activates factor XI on activated platelets in the absence of factor XII Arterioscler. Thromb. Vasc. Biol. 19 1999 170 177
61. D.H. Ho, K. Badellino, F.A. Baglia, M.F. Sun, M.M. Zhao, and D. Gailani The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface J. Biol. Chem. 275 2000 25139 25145
62. F.A. Baglia, K.O. Badellino, C.Q. Li, J.A. Lopez, and P.N. Walsh Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin J. Biol. Chem. 277 2002 1662 1668
63. T.H. Yun, F.A. Baglia, T. Myles, D. Navaneetham, J.A. Lopez, and P.N. Walsh Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively J. Biol. Chem. 278 2003 41112 41119
64. F.A. Baglia, C.N. Shrimpton, J.A. Lopez, and P.N. Walsh The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane J. Biol. Chem. 278 2003 21744 21750
65. S.J.H. Wielders, S.H. Beguin, H.C. Hemker, and T. Lindhout Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available Arterioscler. Thromb. Vasc. Biol. 24 2004 1138 1142
66. H. Soons, T. Janssen-Claessen, H.C. Hemker, and G. Tans The effect of platelets in the activation of human blood coagulation factor IX by factor XIa Blood 68 1986 140 148
67. P.N. Walsh, D. Sinha, A. Koshy, F.S. Seaman, and H. Bradford Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface Blood 68 1986 225 230
68. T.R. Baird, and P.N. Walsh The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation J. Biol. Chem. 277 2002 38462 38467
69. U. Seligsohn Factor XI deficiency Thromb. Haemost. 70 1993 68 71
70. R. Asakai, E.W. Davie, and D.W. Chung Organization of the gene for human factor XI Biochemistry 26 1987 7221 7228
71. A. Kato, R. Asakai, E.W. Davie, and N. Aoki Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4 Cytogenet. Cell Genet. 52 1989 77 78
72. U. Seligsohn R.M. Goodman A.G. Motulsky Genetic diseases among Ashkenazi Jews 1979 Raven New York 141 147
73. R. Asakai, D.W. Chung, O.D. Ratnoff, and E.W. Davie Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations Proc. Natl. Acad. Sci. U. S. A. 86 1989 7667 7671
74. R. Asakai, D.W. Chung, E.W. Davie, and U. Seligsohn Factor XI deficiency in Ashkenazi Jews in Israel N. Engl. J. Med. 325 1991 153 158
75. J.C. Meijers, E.W. Davie, and D.W. Chung Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency Blood 79 1992 1435 1440
76. H. Saito, O.D. Ratnoff, B.N. Bouma, and U. Seligsohn Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds J. Lab. Clin. Med. 106 1985 718 722
77. H. Peretz, A. Zivelin, S. Usher, and U. Seligsohn A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency Human Mutat. 8 1996 77 78
78. F. Bauduer, F. Dupreuilh, L. Ducout, and B. Marti Factor XI deficiency in the French Basque Country Haemophilia 5 1999 187 190
79. A. Zivelin, F. Bauduer, L. Ducout, H. Peretz, N. Rosenberg, and R. Yatuv Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene Blood 99 2002 2448 2454
80. F. Quelin, M. Trossaert, M. Sigaud, P.DE. Mazancourt, and E. Fressinaud Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation J. Thromb. Haemost. 2 2004 71 76
81. P.H. Bolton-Maggs, H. Peretz, R. Butler, R. Mountford, S. Keeney, and L. Zacharski A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency J. Thromb. Haemost. 2 2004 918 924
82. M.F. Sun, F.A. Baglia, D. Ho, D. Martincic, R.E. Ware, and P.N. Walsh Defective binding of factor XI-N248 to activated human platelets Blood 98 2001 125 129
83. D.V. Kravtsov, W. Wu, J.C. Meijers, M.F. Sun, M. Blinder, and T.P. Dang Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain Blood 104 2004 128 134
84. A.E. Schmidt, T. Ogawa, D. Gailani, and S.P. Bajaj Structural role of Gly193 in serine proteases: investigations of Gly555Glu (Gly193 in chymotrypsin) mutant of blood coagulation factor XI J. Biol. Chem. 279 2004 29485 29492